These patients with variants can be associated with diabetes phenotypes or clinical features involving the GCK or HNF1β gene, such as age of onset of diagnosis, level of secretion of insulin during an OGTT, or renal dysplasia or abnormality. This evidence concerns the gene GCK and diabetes mellitus.